Rare Pediatric Disease Priority Review Voucher (PRV) granted by FDA at approval to be transferred from Sentynl Therapeutics to Cyprium Cyprium eligible to receive tiered royalties and up to $129 milli ...

Leading event to bridge research, clinical adoption, and investment in microbiome-enabled health hosted by CE-Ventures, the ...

Rare Pediatric Disease Priority Review Voucher (PRV) granted by FDA at approval to be transferred from Sentynl Therapeutics ...

Shah laid the foundation stone of the BSL-4 Bio-Containment Facility of the Gujarat Biotechnology Research Centre in ...

Once-touted 11th Avenue biotech corridor faces reset as Hudson Research Center is recapitalized amid slower life sciences ...

The biology-first hair care brand has brought the hair stylist and forecaster on as Global Brand Ambassador as it sets out to ...

He Jiankui spent three years in prison after creating gene-edited babies. Now back at work, he sees a greater opening for ...

The annual list spotlights the innovations poised to make the greatest impact on our world and shape the future of technology.

Mature biopharma deals are stealing all the headlines, but Bristol Myers Squibb’s Robert Plenge says the company’s deals with ...

The biopharmaceutical sector finally regained its footing in 2025. Here are five issues that could determine whether the ...

The engagement will explore the use of cellular fermentation to make key starting materials required for pharmaceutical ...

The team brings a strong balance of scientific and commercial expertise, has built a unique data foundation with a ...